Molecular mechanisms regulating human CYP4B1 lung-selective expression

Drug Metabolism and Disposition

Volumn 33, Issue 8, 2005, Pages 1174-1184

  Poch, Mark T ^a   Cutler, N Shane ^b   Yost, Garold S ^b   Hines, Ronald N ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 4B1; LUCIFERASE; SEPHADEX; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ARTICLE; CHROMATIN; CONTROLLED STUDY; DNA BINDING; GEL MOBILITY SHIFT ASSAY; HEPATOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER; LUNG; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; BINDING SITES; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; DNA; GENE EXPRESSION REGULATION; GENES, REGULATOR; GENES, REPORTER; HUMANS; LUNG; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 22944472719     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.105.004523     Document Type: Article

References (39)

1. Anderson KP, Kern CB, Crable SC, and Lingrel JB (1995) Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Kruppel-like factor: identification of a new multigene family. Mol Cell Biol 15:5957-5965.
2. Apt D, Watts RM, Suske G, and Bernard HU (1996) High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology 224:281-291.
3. Boucher PD, Ruch RJ, and Hines RN (1993) Specific nuclear protein binding to a negative regulatory element on the human CYP1A1 gene. J Biol Chem 268:17384-17391.
4. Boulanger A, Liu S, Henningsgaard AA, Yu S, and Redmond TM (2000) The upstream region of the Rpe65 gene confers retinal pigment epithelium-specific expression in vivo and in vitro and contains critical octamer and E-box binding sites. J Biol Chem 275:31274-31282.
5. Chadjichristos C, Ghayor C, Herrouin JF, Ala-Kokko L, Suske G, Pujol JP, and Galera P (2002) Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. J Biol Chem 277:43903-43917.
6. Chodosh LA (1988) Mobility shift DNA-binding assay using gel electrophoresis, in Current Protocols in Molecular Biology (Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K eds) pp 12.2.1-12.2.10, Greene Publishing and Wiley-Interscience, New York.
7. Czerwinski M, McLemore TL, Gelboin HV, and Gonzalez FJ (1994) Quantification of CYP2B7, CYP4B1 and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res 54:1085-1091.
8. Dahl AR and Lewis JL (1993) Respiratory tract uptake of inhalants and metabolism of xenobiotics. Annu Rev Pharmacol Toxicol 33:383-407.
9. Ding X and Kaminsky LS (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149-173.
10. Guengerich FP (1993) The 1992 Bernard B. Brodie Award Lecture: bioactivation and detoxication of toxic and carcinogenic chemicals. Drug Metab Dispos 21:1-6.
11. Hata Y, Duh E, Zhang K, Robinson GS, and Aiello LP (1998) Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence. J Biol Chem 273:19294-19303.
12. Hukkanen J, Vaisanen T, Lassila A, Piipari R, Anttila S, Pelkonen O, Raunio H, and Hakkola J (2003) Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells. J Pharmacol Exp Ther 304:745-752.
13. Imaoka S, Hayashi K, Hiroi T, Yabusaki Y, Kamataki T, and Funae Y (2001) A transgenic mouse expressing human CYP4B1 in the liver. Biochem Biophys Res Commun 284:757-762.
14. Imaoka S, Yoneda Y, Sugimoto T, Hiroi T, Yamamoto K, Nakatani T, and Funae Y (2000) CYP4B1 is a possible factor for bladder cancer in humans. Biochem Biophys Res Commun 277:776-780.
15. Kriwacki RW, Schultz SC, Steitz TA, and Caradonna JP (1992) Sequence-specific recognition of DNA by zinc-finger peptides derived from the transcription factor Sp1. Proc Natl Acad Sci USA 89:9759-9763.
16. Li L, He S, Sun JM, and Davie JR (2004) Gene regulation by Sp1 and Sp3. Biochem Cell Biol 82:460-471.
17. Li RC, Ping P, Zhang J, Wead WB, Cao X, Gao J, Zheng Y, Huang S, Han J, and Bolli R (2000) PKCε modulates NF-κB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol 279:H1679-H1689.
18. Mahoney CW, Shuman J, McKnight SL, Chen H-C, and Huang K-P (1992) Phosphorylation of CCAAT-enhancer binding protein by protein kinase C attenuates site-selective DNA binding. J Biol Chem 267:19396-19403.
19. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, et al. (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31:374-378.
20. Nebert DW and Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162.
21. Overdier DG, Porcella A, and Costa RH (1994) The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino acid residues adjacent to the recognition helix. Mol Cell Biol 14:2755-2766.
22. Rao MK, Maiti S, Ananthaswamy HN, and Wilkinson MF (2002) A highly active homeobox gene promoter regulated by Ets and Sp1 family members in normal granulosa cells and diverse tumor cell types. J Biol Chem 277:26036-26045.
23. Rettie AE, Sheffels PR, Korzekwa KR, Gonzalez FJ, Philpot RM, and Baillie TA (1995) CYP4 isozyme specificity and the relationship between omega-hydroxylation and terminal desaturation of valproic acid. Biochemistry 34:7889-7895.
24. Rivera SP, Saarikoski ST, and Hankinson O (2002) Identification of a novel dioxin-inducible cytochrome P450. Mol Pharmacol 61:255-259.
25. Roesler WJ, Vandenbark GR, and Hanson RW (1988) Cyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem 263:9063-9066.
26. Saffer JD, Jackson SP, and Annarella MB (1991) Developmental expression of Sp1 in the mouse. Mol Cell Biol 11:2189-2199.
27. Sanger F, Nicklen S, and Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
28. Shang Y, Hu X, DiRenzo J, Lazar MA, and Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
29. Smith PB, Tiano HF, Nesnow S, Boyd MR, Philpot RM, and Langenbach R (1995) 4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1. Biochem Pharmacol 50:1567-1575.
30. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
31. Sowa Y, Orita T, Minamikawa-Hiranabe S, Mizuno T, Nomura H, and Sakai T (1999) Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res 59:4266-4270.
32. Su W, Jackson S, Tjian R, and Echols H (1991) DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1. Genes Dev 5:820-826.
33. Suske G (1999) The Sp-family of transcription factors. Gene 238:291-300.
34. Vanderslice RR, Boyd JA, Eling TE, and Philpot RM (1985) The cytochrome P-450 monooxygenase system of rabbit bladder mucosa: enzyme components and isozyme 5-dependent metabolism of 2-aminofluorene. Cancer Res 45:5851-5858.
35. Wan J, Carr BA, Cutler NS, Lanza DL, Hines RN, and Yost GS (2005) Sp1 and Sp3 regulate basal transcription of the human CYP2F1 gene. Drug Metab Dispos, in press.
36. Xin J-H, Cowie A, Lachance P, and Hassell JA (1992) Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev 6:481-496.
37. p-2 from the cDNA library of human placenta. Gene structure and expression. Eur J Biochem 187:23-29.
38. Yu B, Datta PK, and Bagchi S (2003) Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites. Nucleic Acids Res 31:5368-5376.
39. Zheng Y-M, Henne KR, Charmley P, Kim RB, McCarver DG, Cabacungan ET, Hines RN, and Rettie AE (2003) Genotyping and site-directed mutagenesis of a cytochrome P450 meander Pro-X-Arg motif critical to CYP4B1 catalysis. Toxicol Appl Pharmacol 186:119-126.